ArticleOncology reports2019
miR‑505 suppresses prostate cancer progression by targeting NRCAM.
Xiao-Hui Ling et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it
ArticleOncology reports2019
Xiao-Hui Ling et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.